Dysfibrinogenemia in childhood: Two cases of congenital dysfibrinogens

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 7, 2010, Pages 640-648

  Kotlín, Roman ^a   Blažek, Bohumír ^b   Suttnar, Jiří ^a   Malý, Martin ^c   Kvasnička, Jan ^d   Dyr, Jan E ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

dysfibrinogenemia; fibrinogen; fibrinopeptide A; missense mutation

Indexed keywords

ARGININE; FIBRINOGEN; FIBRINOPEPTIDE; HISTIDINE;

ARTICLE; BLOOD CLOTTING TEST; CASE REPORT; CHILD; DNA DETERMINATION; DNA EXTRACTION; DNA SEQUENCE; DYSFIBRINOGENEMIA; FIBRIN POLYMERIZATION; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; GENE MUTATION; GENETIC IDENTIFICATION; HETEROZYGOTE DETECTION; HUMAN; MALE; MASS SPECTROMETRY; POINT MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SCHOOL CHILD; THROMBIN TIME; TURBIDIMETRY;

AFIBRINOGENEMIA; CHILD; DNA MUTATIONAL ANALYSIS; FIBRIN; FIBRINOGEN; HETEROZYGOTE; HUMANS; INFANT; MALE; POINT MUTATION; SIBLINGS; THROMBIN TIME;

EID: 77958199118     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32833e4284     Document Type: Article

References (31)

1. Moen JL, Lord ST. Afibrinogenemias and dysfibrinogenemias. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, editors. Hemostasis and thrombosis basic principles and clinical practice, 5th ed. Philadelphia, USA: Lippincott Williams & Wilkins; 2006. pp. 939- 952.
2. Henschen AH, McDonagh J. Fibrinogen, fibrin and factor XIII. In: Zwaal RFA, Hemker HC, editors. Blood coagulation. Amsterdam, The Netherlands: Elsevier Science Publishers; 1986. pp. 171-241.
3. UCSC Genome Browser. http://genome.ucsc.edu/cgi-bin/ hgTracks?position= chr4 : 155100001-161500000&hgsid=106991619.
4. Olexa SA, Budzynski AZ. Localization of a fibrin polymerization site. J Biol Chem 1981; 256:3544-3549.
5. Furlan M, Leupin L, Demamels Biasiutti F, Lämmle B. Fibrinogen Bern III: Ein weiterer Fall der hereditären Fibrinogenvariante mit Substitution Aa 16 Arg ! Cys. Schweiz Med Wochenschr 1991; 121:1068-1071.
6. Stücki B, Zenhäusern R, Biedermann B, Baudo F, Redaelli R, Lämmle B, et al. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aa-chain. Blood Coagul Fibrinolysis 1999; 10:93-99. (Pubitemid 29145173)
7. Mathonnet F, Peltier JY, Roda L, de Raucourt E, D'Hailly F, Tetegan M, et al. Three new cases of dysfibrinogenemia Poissy III, Saint-Germain I and Tahiti. Thromb Res 2001; 103:201-207. (Pubitemid 32728105)
8. Kotlín R, Chytilová M, Suttnar J, Riedel T, Salaj P, Blatný J, et al. Fibrinogen Nový Jic? ín and Praha II: cases of hereditary Aalpha 16 Arg ! Cys and Aalpha 16 Arg ! His dysfibrinogenemia. Thromb Res 2007; 121:75-84. (Pubitemid 350025994)
9. Hanss M, Biot F. A database for human fibrinogen variants. Ann N Y Acad Sci 2001; 936: 89-90. http://www.geht.org/databaseang/fibrinogen. (Pubitemid 32613894)
10. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood 1992; 80:1998-2005.
11. Witt I, Müller H. Phosphorus and hexose content of human foetal fibrinogen. Biochim Biophys Acta 1970; 221:402-404.
12. Maurer MC, Peng J-L, An SS, Trosset JY, Henschen-Edman A, Scheraga HA. Structural examination of the influence of phosphorylation on the binding of fibrinopeptide A to bovine thrombin. Biochemistry 1998; 37:5888-5902. (Pubitemid 28196740)
13. Brennan SO, Hammonds B, George PM. Aberrant hepatic processing causes removal of activation peptide and primary polymerization site from fibrinogen Canterbury (Aa Val ! Asp). J Clin Invest 1995; 96:2854-2858. (Pubitemid 126841228)
14. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins from silver stained polyacrylamide gels. Anal Chem 1996; 68:850-858. (Pubitemid 26101214)
15. Kotlín R, Chytilová M, Suttnar J, Salaj P, Riedel T, Santru° cek J, et al. A novel fibrinogen variant: Praha I - hypofibrinogenemia associated with g 351Gly ! Ser substitution. Eur J Haematol 2007; 78:410-416. (Pubitemid 46558200)
16. Kotlín R, Sobotková A, Suttnar J, Salaj P, Walterová L, Riedel T, et al. A novel fibrinogen variant: Liberec - dysfibrinogenaemia associated with gamma Tyr262Cys substitution. Eur J Haematol 2008; 81:123-129. (Pubitemid 352019636)
17. Kotlín R, Sobotková A, Riedel T, Salaj P, Suttnar J, Reicheltová Z, et al. Acquired dysfibrinogenemia secondary to multiple myeloma. Acta Haematol 2008; 120:75-81.
18. Suttnar J, Dyr JE, For?tová H, Pristach J. Determination of fibrinopeptides by high performance liquid chromatography. Biochem Clin Bohemoslov 1989; 18:17-25. (Pubitemid 19069787)
19. Kotlín R, Reicheltová Z, Malý M, Suttnar J, Sobotková A, Salaj P, et al. Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzen? . Thromb Haemost 2009; 102:479-486.
20. Miller SA, Dykes PD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acid Res 1988; 16:1215.
21. Stubbs MT, Bode W. The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur J Biochem 1992; 206:187-195.
22. Huang S, Mulvihill ER, Farrell DH, Chung DW, Davie EW. Biosynthesis of human fibrinogen. Subunit interactions and potential intermediates in assembly. J Biol Chem 1993; 268:8919-8926. (Pubitemid 23118685)
23. Roy S, Sun A, Redman C. In vitro assembly of the component chains of fibrinogen requires endoplasmic reticulum factors. J Biol Chem 1996; 271:24544-24550. (Pubitemid 26333192)
24. Lane DA, Ireland H, Thompson E, Frost TJ, Cuddigan B. Two more fibrinogens (London III and Sydney) with impaired fibrinopeptide release. Thromb Res 1982; 28:821-824. (Pubitemid 13179772)
25. Lee MH, Kaczmarek E, Chin DT, Oda A, McIntosh S, Bauer KA, et al. Fibrinogen Ledyard (AaArg16 ! Cys): biochemical and physiologic characterization. Blood 1991; 78:1744-1752.
26. Reber P, Furlan M, Beck EA, Finazzi G, Buelli M, Barbui T. Fibrinogen Bergamo I (Aa16Arg ! Cys): Susceptibility towards thrombin following aminoethylation, methylation or carboxyamidomethylation of cysteine residues. Thromb Haemost 1985; 54:390-393. (Pubitemid 16252455)
27. Loreth RM, Meyer M, Albert FW. Fibrinogen Kaiserslautern III: A new case of congenital dysfibrinogenemia with Aa 16 Arg ! Cys substitution. Haemostasis 2001; 31:12-17. (Pubitemid 32620132)
28. Bolliger-Stücki B, Lord ST, Furlan M. Fibriongen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, Aa R16C and g G165R. Blood 2001; 98:351-357.
29. Soria J, Soria C, Samama M, Poirot E, Kling C. Fibrinogen Troyes- Fibrinogen Metz. Two cases of congenital dysfibrinogenemia. Thromb Diath Haemorrh 1972; 27:619-633.
30. Weisel JW. The mechanical properties of fibrin for basic scientists and clinicians. Biophys Chem 2004; 112:267-276. (Pubitemid 39574429)
31. Koopman J, Haverkate F, Grimbergen J, Lord ST, Mosesson MW, DiOrio JP, et al. Molecular basis for fibrinogen Dusart (A alpha 554 Arg!Cys) and its association with abnormal fibrin polymerization and thrombophilia. J Clin Invest 1993; 91:1637-1643. (Pubitemid 23127367)